Gilead Sciences (GILD) Prepaid Assets (2009 - 2026)

Gilead Sciences (GILD) posted Prepaid Assets of $4.3 billion for Q1 2026, up 7.9% quarter-over-quarter from $4.0 billion in Q4 2025, and up 53.54% year-on-year from $2.8 billion in Q1 2025.

Gilead Sciences (GILD) Prepaid Assets (2009 - 2026) Analysis & Trends

Gilead Sciences (GILD) has reported Prepaid Assets for 18 consecutive years, with $4.3 billion the latest figure, recorded in Q1 2026.

  • Prepaid Assets for Q1 2026 came in at $4.3 billion, up 53.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.3 billion (up 53.54% YoY), and the FY2025 annual result was $4.0 billion, up 31.85% from the prior year.
  • Prepaid Assets was $4.3 billion for Q1 2026 at Gilead Sciences, up from $4.0 billion in the prior quarter.
  • Over five years, Prepaid Assets peaked at $4.3 billion in Q1 2026 and troughed at $1.8 billion in Q2 2023.
  • Average Prepaid Assets over 5 years is $2.7 billion, with a median of $2.8 billion recorded in 2024.
  • Year-over-year, Prepaid Assets decreased 17.14% in 2022 and surged 62.55% in 2024.
  • Over 5 years, Prepaid Assets stood at $1.8 billion in 2022, then soared by 33.82% to $2.4 billion in 2023, then advanced by 28.56% to $3.1 billion in 2024, then soared by 31.85% to $4.0 billion in 2025, then increased by 7.9% to $4.3 billion in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $4.3 billion in Q1 2026, $4.0 billion in Q4 2025, and $3.6 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.34 Bn
Dec 31, 2025 4.02 Bn
Sep 30, 2025 3.65 Bn
Jun 30, 2025 2.90 Bn
Mar 31, 2025 2.83 Bn
Dec 31, 2024 3.05 Bn
Sep 30, 2024 3.29 Bn
Jun 30, 2024 2.86 Bn
Mar 31, 2024 2.80 Bn
Dec 31, 2023 2.37 Bn
Sep 30, 2023 2.66 Bn
Jun 30, 2023 1.76 Bn
Mar 31, 2023 1.85 Bn
Dec 31, 2022 1.77 Bn
Sep 30, 2022 2.08 Bn
Jun 30, 2022 1.90 Bn
Mar 31, 2022 2.04 Bn
Dec 31, 2021 2.14 Bn
Sep 30, 2021 2.01 Bn
Jun 30, 2021 1.48 Bn